FRIEL ROBERT F 4

What Happened

Robert Friel, a member of the board of directors of West Pharmaceutical Services, Inc. (WST), received a grant of 791 restricted stock units (RSUs) on 2026-05-04. The award is reported at $0.00 per share (code A — grant/award), meaning no cash was paid for the units; value will be realized when shares are distributed upon vesting.

Key Details

• Transaction date: 2026-05-04; Form 4 filed: 2026-05-06.
• Transaction type: Award/Grant (RSUs) — 791 shares @ $0.00.
• Shares owned after transaction: not disclosed in this filing.
• Footnote: These RSUs will vest in full on the date of the next annual shareholder meeting and will be distributable under the Deferred Compensation Plan for Outside Directors.
• No indication of a sale or purchase; this is a compensation-related grant to a non-employee director.

Context

RSU grants to outside directors are common as part of board compensation and are typically intended for retention and alignment with shareholders; they do not reflect an open-market purchase or sale by the insider. The vesting schedule (full vest at the next annual meeting) means shares are not immediately transferable and become distributable once vesting conditions are met.